Emapalumab Prevention of CAR-T Cell Associated Toxicities

Clinical trial NCT06550141 · RECRUITING

Trial details

NCT number: NCT06550141
Sponsor: Marcela V. Maus, M.D.,Ph.D.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Primary Mediastinal Large B-cell Lymphoma High-grade B-cell Lymphoma Follicular Lymphoma

Start date: 2024-09-18
Primary completion: 2026-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.